Azenta, Inc. (AZTA) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Azenta, Inc. (AZTA) PT Lowered to $48 at Evercore ISI
November 13, 2024 5:43 AM ESTEvercore ISI analyst Vijay Kumar lowered the price target on Azenta, Inc. (NASDAQ: AZTA) to $48.00 (from $50.00) while maintaining a In Line rating.
The analyst comments 4Q Results: AZTAs org revs declined -2%, with total revs of $170 MM inline with ST. SMS... More
Azenta, Inc. (AZTA) to Sell B Medical Systems, Appoints Lawrence Y. Lin as CFO
November 12, 2024 4:06 PM ESTAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024.
Fiscal Year 2024 Highlights:
Q4'24 revenue growth of 6% reported and 5% organic, in combined Sample Management Solutions and MultiomicsFY'24 Adjusted EBITDA margin expansion of approximately 300 basis points versus last year
Quarter Ended
... More


